Multiple System Atrophy (MSA) (DBCOND0055000)

Identifiers

Synonyms
MSA - Multiple System Atrophy / Multiple Systems Atrophy / Multiple System Atrophy, MSA / Multiple System Atrophy / Multiple system atrophy (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Droxidopa
A medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02795052
Neurologic Stem Cell Treatment StudyNo drug interventionstreatmentNot Availablerecruiting
NCT06120049
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DBL vs. ADNo drug interventionsdiagnostic2 / 3not_yet_recruiting
NCT05696717
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophytreatment3recruiting
NCT05698017
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early- to Moderate Stage MSANo drug interventionstreatment1 / 2recruiting
NCT05197816
MotIoN aDaptive Deep Brain Stimulation for MSANo drug interventionstreatmentNot Availablerecruiting
NCT04753320
Remote Monitoring in Progressive Supranuclear Palsy (PSP)No drug interventionsNot AvailableNot Availablerecruiting
NCT05011773
Manipulating and Optimising Brain Rhythms for Enhancement of SleepNo drug interventionsbasic_scienceNot Availablecompleted
NCT03577483
Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech AnalysisNo drug interventionsdiagnosticNot Availablecompleted
NCT05792332
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)No drug interventionssupportive_careNot Availablerecruiting
NCT05486806
Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement DisordersNo drug interventionsNot AvailableNot Availablerecruiting
NCT02194816
Modifiable Variables in Parkinsonism (MVP)No drug interventionsNot AvailableNot Availablerecruiting
NCT04680130
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersNot AvailableNot Availableenrolling_by_invitation
NCT01927055
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapytreatment3terminated
NCT02388295
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patientstreatment2completed
NCT06204575
Focused Ultrasound Thalamotomy for Tremor Relief in Atypical ParkinsonismNo drug interventionsNot AvailableNot Availablecompleted
NCT05923866
A Phase 2 Study of ONO-2808 in Patients With Multiple System AtrophyNo drug interventionstreatment2recruiting
NCT01888185
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)No drug interventionsNot AvailableNot Availablecompleted
NCT01485549
Oligomeric Alpha-synuclein in Multiple System AtrophyNo drug interventionsNot AvailableNot Availablecompleted
NCT03811808
Multiple System Atrophy Multidisciplinary ClinicNo drug interventionsNot AvailableNot Availablerecruiting
NCT02778607
PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UKNo drug interventionsNot AvailableNot Availableunknown_status
NCT04193527
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patientsdiagnostic3completed
NCT05086094
Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)Not AvailableNot Availableno_longer_available
NCT02796209
Norepinephrine Transporter Blockade, Autonomic FailureNo drug interventionstreatment2completed
NCT04620382
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patientsother0recruiting
NCT05104476
A Study of Lu AF82422 in Participants With Multiple System AtrophyNo drug interventionstreatment2active_not_recruiting
NCT06607900
HUC-MSC-sEV-001 Nasal Drops for Neurodegenerative DiseasesNo drug interventionstreatment1not_yet_recruiting
NCT05695378
Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)No drug interventionstreatment2terminated
NCT06596746
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)No drug interventionsNot AvailableNot Availablerecruiting
NCT06597071
Parkinson Atypical Rating of Oculometric Patterns Evaluated RoutinelyNo drug interventionsotherNot Availableenrolling_by_invitation
NCT00465790
Research of Biomarkers in Parkinson DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01287221
Study of Rifampicin in Multiple System Atrophytreatment3terminated
NCT05167721
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System AtrophyNo drug interventionstreatment2recruiting
NCT02008721
Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approachtreatment3completed
NCT03872102
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using NeuroimagingNo drug interventionsNot AvailableNot Availablerecruiting
NCT03552484
In-Home Care for Patients With PSP and Related DisordersNo drug interventionssupportive_careNot Availablecompleted
NCT04782284
Comprehensive Swallowing Rehabilitation in Patients With MSANo drug interventionstreatmentNot Availablerecruiting
NCT02185677
Cognitive and Behavioral Dysexecutive Syndrome in Multiple System AtrophyNo drug interventionsNot AvailableNot Availablecompleted
NCT05638477
Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian DisordersNo drug interventionsdiagnosticNot Availablerecruiting
NCT04020198
A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With SynucleinopathiesNo drug interventionsNot AvailableNot Availableunknown_status
NCT03648905
Clinical Laboratory Evaluation of Chronic Autonomic FailureNot AvailableNot Availableactive_not_recruiting
NCT00103597
Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophytreatment1completed
NCT03482297
Automated Abdominal Binder for Orthostatic Hypotensiontreatment1 / 2recruiting
NCT00653783
Diagnostic and Prognostic Biomarkers in Parkinson DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT02726711
Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomicbasic_science1active_not_recruiting
NCT00547911
Augmenting Effects of L-DOPS With Carbidopa and Entacaponetreatment1 / 2terminated
NCT01044693
Nebivolol in the Supine Hypertension of Autonomic FailureNot AvailableNot Availablecompleted
NCT03076671
More Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT03446807
Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonismtreatment2withdrawn
NCT03452956
Cognitive Impairement In Frontotemporal DementiaNo drug interventionsNot AvailableNot Availablecompleted
NCT02417415
Local Heat Stress in Autonomic Failure Patients With Supine HypertensionNo drug interventionsotherNot Availablecompleted
NCT05638815
An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)No drug interventionsNot AvailableNot Availablecompleted
NCT06209515
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04246437
[18F]F-DOPA Imaging in Patients With Autonomic Failurebasic_science1recruiting
NCT04518059
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other ParkinsonismNo drug interventionsNot AvailableNot Availablerecruiting
NCT02071459
Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSAtreatment2 / 3completed
NCT05489575
CPAP for the Treatment of Supine HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT05139342
Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT03952806
Study of BHV-3241 in Participants With Multiple System Atrophytreatment3completed
NCT00758849
Fipamezole in Neurogenic Orthostatic Hypotensiontreatment2unknown_status
NCT00001549
Diagnosis and Natural History Study of Patients With Neurological ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT03120013
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative AtaxiaNo drug interventionstreatmentNot Availablecompleted
NCT01136213
Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00822913
Botulinum A Toxin in Patients With Parkinson's Diseasetreatment4unknown_status
NCT04468919
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation ToolkitNo drug interventionsbasic_scienceNot Availablerecruiting
NCT02994719
Gait Analysis in Neurological DiseaseNot AvailableNot Availablerecruiting
NCT01119417
The Role of Endothelin in the Supine Hypertension of Autonomic Failureother1withdrawn
NCT04706234
Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat TauopathiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00742586
Autonomic Failure Patients for RNA Blood SamplingNo drug interventionsNot AvailableNot Availablecompleted
NCT05222386
Community Outreach for Palliative Engagement -- Parkinson DiseaseNo drug interventionstreatmentNot Availablerecruiting
NCT02640339
Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04700722
Synuclein-One StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04965922
Quality of Life of Caregivers and Patients Suffering From Multiple System AtrophyNo drug interventionssupportive_careNot Availableunknown_status
NCT04313530
TMS Treatment in Multiple System Atrophy With FatigueNo drug interventionstreatmentNot Availableunknown_status
NCT04472130
Neurodegenerative Diseases RegistryNo drug interventionsNot AvailableNot Availableunknown_status
NCT06174948
The Use of the CUE1 in People With Parkinson's Disease and Related DisordersNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02429557
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failureother1recruiting
NCT05819957
Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their CaregiversNo drug interventionsdiagnosticNot Availablerecruiting
NCT02064166
Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.treatment2completed
NCT01316666
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic HypotensionNo drug interventionsNot AvailableNot Availablecompleted
NCT00977665
Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)treatment2completed
NCT04495582
Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03589976
A Futility Trial of Sirolimus in Multiple System Atrophytreatment2terminated
NCT05634876
UB-312 in Patients With SynucleinopathiesNo drug interventionstreatment1 / 2active_not_recruiting
NCT05889260
Speech Accessibility ProjectNo drug interventionsNot AvailableNot Availablerecruiting
NCT05526391
A Study of TAK-341 in Treatment of Multiple System AtrophyNo drug interventionstreatment2active_not_recruiting
NCT05109091
Study of ATH434 in Participants With Multiple System Atrophytreatment2active_not_recruiting
NCT02270489
Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSANo drug interventionstreatment1completed
NCT01577992
Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophybasic_scienceNot Availablecompleted
NCT04450992
TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System AtrophyNo drug interventionsNot AvailableNot Availablecompleted
NCT06221644
Synapse Alterations in MSA PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03265444
Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System AtrophyNo drug interventionstreatment1completed
NCT03269201
Brain Network Activation in Patients With Movement DisordersNo drug interventionsNot AvailableNot Availableunknown_status
NCT02149901
Water and Sudafed in Autonomic Failureother0terminated
NCT00997672
Lithium in Multiple System Atrophytreatment2terminated
NCT02445469
Magnetic Resonance Imaging in the Diagnosis of Parkinsonian SyndromesNo drug interventionsdiagnosticNot Availableterminated
NCT04153110
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative AtaxiaNo drug interventionstreatmentNot Availablecompleted
NCT03174938
The Swedish BioFINDER 2 StudyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03901638
Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System AtrophyNo drug interventionstreatment3terminated
NCT03721887
Exploit the Neural Source and the Feasibility of Transcranial Direct Current Stimulation for Freezing of Gait in Parkinson's Disease and Multiple System AtrophyNo drug interventionstreatmentNot Availableunknown_status
NCT05238545
The Effect of Gluten-free Diet on ParkinsonismNo drug interventionstreatmentNot Availablerecruiting
NCT06072105
Medical Decision Making in Multiple System AtrophyNo drug interventionssupportive_careNot Availablerecruiting
NCT05171205
Spinal Cord Stimulation for Multiple System AtrophyNo drug interventionstreatmentNot Availablerecruiting
NCT01353183
Analysis of the Enteric Nervous System Using Colonic BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT00743561
Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)No drug interventionsdiagnosticNot Availablecompleted
NCT05748028
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical ParkinsonismsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04250493
Insulin Resistance in Multiple System Atrophyhealth_services_researchNot Availableunknown_status
NCT04858893
Application of Machine Learning Method in Validation of Screening Cognitive Test for ParkinsonismsNo drug interventionsNot AvailableNot Availablecompleted
NCT03042988
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine HypertensionNo drug interventionstreatmentNot Availablerecruiting
NCT02761707
Biomarkers in Neural DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT03403309
Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trialtreatment2completed
NCT04616456
Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patientstreatment0completed
NCT01799915
Natural History Study of SynucleinopathiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT06568237
A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy Safety and Efficacy StudyNo drug interventionstreatment2recruiting
NCT02132052
Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.No drug interventionsNot AvailableNot Availablecompleted
NCT05621200
Transcranial Alternating Current Stimulation (tACS) in Patients With AtaxiaNo drug interventionstreatmentNot Availablecompleted
NCT04287270
Respiratoy Muscle Strength in Patients With Multiple System AtrophyNo drug interventionshealth_services_researchNot Availablecompleted
NCT02114242
Biomarkers in Parkinsonian SyndromesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00368199
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian SyndromesNo drug interventionsNot AvailableNot Availablecompleted
NCT06203106
NYSCF Scientific Discovery BiobankNo drug interventionsNot AvailableNot Availablerecruiting
NCT04431713
Exenatide Once-weekly as a Treatment for Multiple System Atrophytreatment2unknown_status
NCT06162013
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical ParkinsonismNo drug interventionstreatment2recruiting
NCT00211224
Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)treatment3terminated
NCT02428816
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian SyndromesNo drug interventionsdiagnosticNot Availablecompleted
NCT05453058
Observational Study in Multiple System AtrophyNo drug interventionsNot AvailableNot Availablecompleted
NCT02897063
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failurebasic_science1recruiting
NCT04184063
Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)No drug interventionstreatment2completed
NCT03753763
Safinamide for Multiple System Atrophy (MSA)treatment2completed
NCT04165486
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)No drug interventionstreatment1recruiting
NCT04782830
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension SymptomsotherNot Availablerecruiting
NCT01146548
Fluoxetine in Multiple System Atrophy Patientssupportive_care2completed
NCT05826457
North American Prodromal Synucleinopathy Consortium Stage 2No drug interventionsNot AvailableNot Availablerecruiting
NCT04876326
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System AtrophyNo drug interventionstreatmentNot Availableunknown_status
NCT06490926
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian SyndromeNo drug interventionsNot AvailableNot Availablerecruiting
NCT00911365
Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System AtrophyNo drug interventionstreatment2completed
NCT05864365
Biomarker Study of ATH434 in Participants With MSANo drug interventionstreatment2active_not_recruiting
NCT04680065
GDNF Gene Therapy for Multiple System AtrophyNo drug interventionstreatment1recruiting
NCT04229173
Natural History and Disease Progression Biomarkers of Multiple System AtrophyNo drug interventionsotherNot Availablecompleted
NCT05807373
Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis - Part 2No drug interventionsdiagnosticNot Availablerecruiting
NCT04844060
Cerebro Spinal Fluid Collection (CSF)No drug interventionsNot AvailableNot Availablerecruiting
NCT05699460
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System AtrophyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01292694
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failurebasic_science1terminated
NCT00738062
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)treatment3completed
NCT05067192
Optimization of Morphomer-based Alpha-synuclein PET TracersNo drug interventionsNot AvailableNot Availablecompleted
NCT01155492
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00750867
Treatment of Multiple System Atrophy Using Intravenous Immunoglobulinstreatment2completed
NCT03623672
North American Prodromal Synucleinopathy ConsortiumNo drug interventionsNot AvailableNot Availableunknown_status
NCT01607268
Magnetic Resonance Spectroscopy in Autonomic FailureNo drug interventionsNot AvailableNot Availableterminated
NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordNo drug interventionsNot AvailableNot Availablerecruiting
NCT06501469
Biomarkers in Parkinsonian SyndromesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03593512
Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System AtrophyNo drug interventionstreatmentNot Availablecompleted
NCT05121012
Synaptic Loss in Multiple System AtrophyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06098612
PET Imaging Evaluation of [11C]SY08basic_science0recruiting
NCT03924414
Trial of Parkinson's And Zoledronic Acidtreatment4recruiting
NCT05732415
Biomarker Study of ATH434 in Participants With MSANo drug interventionstreatment2not_yet_recruiting